Related Experiment Video

Updated: Aug 7, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Aptamer:toxin conjugates that specifically target prostate tumor cells

Ted C Chu1, John W Marks, Laura A Lavery

  • 1Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas 78712, USA.

Cancer Research
|June 17, 2006
PubMed

Insights

RNA aptamer:gelonin conjugates effectively target and destroy cancer cells overexpressing prostate-specific membrane antigen (PSMA). This targeted therapy shows significantly enhanced potency and reduced toxicity in non-target cells, validating escort aptamers for tumor treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Prostate-specific membrane antigen (PSMA) is a cancer biomarker overexpressed in certain tumors.
  • Targeted cancer therapies aim to selectively eliminate cancer cells while sparing healthy ones.

Purpose of the Study:

  • To investigate the efficacy of RNA aptamer:gelonin conjugates in targeting and destroying PSMA-overexpressing cells.
  • To evaluate the potency and specificity of these aptamer:toxin conjugates.

Main Methods:

  • Conjugation of RNA aptamers with the toxin gelonin.
  • Treatment of cell lines with varying PSMA expression levels using the aptamer:toxin conjugates.
  • Assessment of cell viability and toxicity.

Main Results:

  • Aptamer:gelonin conjugates demonstrated an IC50 of 27 nmol/L.
  • Potency was increased at least 600-fold in PSMA-expressing cells compared to non-expressing cells.
  • The aptamer facilitated cellular uptake and reduced gelonin toxicity in non-target cells.

Conclusions:

  • RNA aptamer:gelonin conjugates are effective in selectively targeting and eliminating PSMA-positive cancer cells.
  • "Escort aptamers" show promise as a therapeutic strategy for specific tumors expressing unique antigen targets.

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.